Google plans to launch a pre-censored search engine app in China, tailored to fit China’s strict censorship laws, according to a report in The Intercept.
I was born in 1936 when many of the small towns in the South were controlled by two or three, and in some cases, one family. They owned many of the retail businesses, significant interest in banks and other entities that determined the ebb and flow of available credit in the area and exerted significant influence over local politics.
Last week, left-wing politicians, activists, and columnists gleefully rejoiced that they had unlocked the easy path to single-payer health care in America: Just cut reimbursement payments to health providers by 40 percent and then raise taxes by $32 trillion over the decade. You know, nothing difficult or controversial.
I recently had the pleasure to sit on a panel with a number of incredible inventors and leaders on innovation issues in an experience that was both inspiring and infuriating. Discussing a new documentary on the patent system, “Invalidated: The Shredding of the U.S. Patent System,” which I had the honor of being interviewed for, we discussed the state of the patent system and American innovation.
Last week, authorities in New Mexico discovered 11 children living in a dilapidated compound.
It’s a rock-solid Western conviction: All men—and women—are created equal. But where does it come from? Well, not the Enlightenment.
Sen. Bernie Sanders and congressional candidate Alexandria Ocasio-Cortez are popularizing the philosophy of democratic socialism, especially among younger age groups.
We learned this week that foreign students are more than three times as likely to stay illegally in the country as nonimmigrants as a whole, and we heard several weeks ago that the Department of Homeland Security was — after a gap of 14 years — finally thinking about raising the DHS fees for foreign students.
Greens go apoplectic over rule change that would have no climate or other benefits.
Earlier this week, CNS News reported that the U.S. Food and Drug Administration recently signed a one-year, $15,900 contract with Advanced Bioscience Resources to acquire human fetal tissue “for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system.”